
NAUT
USDNautilus Biotechnolgy Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$0.687
Максимум
$0.708
Минимум
$0.673
Объем
0.01M
Фундаментальные показатели компании
Рыночная капитализация
85.5M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.16M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 4 мая 2025 г.NAUT (Nautilus Biotechnology Inc. Common Stock): What's Happening and What to Watch
Stock Symbol: NAUT Generate Date: 2025-05-04 17:20:18
Alright, let's break down what's going on with Nautilus Biotechnology based on the latest info we've got. Think of this as a quick chat about the stock's recent moves and what might be coming up.
Recent News Buzz
The main piece of news we have is pretty straightforward: Nautilus announced they'll be sharing their first-quarter 2025 financial results on April 29th. This kind of announcement is standard stuff for a company. It tells investors when they'll get the latest look at the company's performance – how much money they made (or didn't), expenses, and so on.
Now, while this specific news item is just a date announcement, the overall "vibe" or sentiment around the stock, according to some analysis tools, seems to be leaning positive right now. It's possible the market is anticipating good results, or maybe there's other positive chatter out there not captured in this single headline. The upcoming earnings call is definitely the big event on the horizon that everyone will be waiting for.
Checking the Price Action
Looking back over the last few months, the picture for NAUT's stock price hasn't been pretty. It's been on a noticeable slide, dropping from the $1.70 range back in February down into the $0.60s more recently. There was a particularly sharp dip around late February.
Lately, though, things have calmed down a bit. The price has been bouncing around in a tighter range, mostly between roughly $0.67 and $0.83 through April and into May. The last price point we have is around $0.68.
Comparing this to the AI's short-term look ahead, the prediction is for the price to stay flat today, then potentially tick up a bit over the next couple of days (around +3% and +4%). This suggests the AI sees the recent downward pressure easing up, at least for the immediate future.
Putting It All Together: What Might Be Next?
So, we've got a stock that's been trending down but seems to have found a floor recently. We have an important date coming up with the earnings report, and despite the recent price history, there's a reported positive sentiment floating around, plus AI predictions pointing to a potential near-term bounce.
Based on these pieces – the AI's forecast for upward movement, the reported positive sentiment (perhaps anticipating earnings), and the stock trading near its recent lows – the situation might suggest a potential opportunity for those looking to buy, if they believe these positive indicators outweigh the recent downward trend.
- Potential Entry Idea: If you were considering getting in, the current price area, around $0.68-$0.70, looks interesting. Why? Because it's right where the stock has been finding some support lately, and it aligns with entry points suggested by some analysis tools. It's essentially near the bottom of its recent trading range.
- Managing Risk: Nobody knows for sure which way a stock will go. If you decide to jump in, thinking about where you'd get out is crucial. A potential level to consider taking some profit, based on the AI's very short-term prediction, could be around $0.71. For a stop-loss – the point where you'd sell to limit potential losses if the price keeps falling – a level like $0.61 has been suggested by some analysis. This is below the recent 52-week low, so it gives the stock some room, but it's important to pick a level you're comfortable with. Remember, these are just ideas based on the data points we have.
A Little Company Context
Just a quick reminder about Nautilus Biotechnology itself: they're a biotech company working on technology to analyze proteins. This means their progress and financial health are tied to developing and selling this specialized platform. News about their technology, research milestones, or, critically, their financial performance (like the upcoming earnings report) can have a big impact on the stock price. They are also a relatively small company by market value, which can sometimes mean bigger price swings.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.
Связанные новости
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 5 мая 2025 г., 10:59
66.2% Уверенность
Риск и торговля
Точка входа
$0.69
Взять прибыль
$0.71
Остановить убытки
$0.61
Ключевые факторы
Связанные акции

TT
Trane Technologies plc

SAJ
Saratoga Investment Corp 8.00% Notes due 2027

FBRT
Franklin BSP Realty Trust Inc.

BTT
BlackRock Municipal 2030 Target Term Trust

UNMA
Unum Group 6.250% Junior Subordinated Notes due 2058
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.